APA (7th ed.) Citation

Salem, J., Bretagne, M., Abbar, B., & Lehmann, L. (2023). Abatacept/ruxolitinib and screening for concomitant respiratory muscle failure to mitigate fatality of immune-checkpoint inhibitor myocarditis. Cancer discovery, 13(5), . https://doi.org/10.1158/2159-8290.CD-22-1180

Chicago Style (17th ed.) Citation

Salem, Joe-Elie, Marie Bretagne, Baptiste Abbar, and Lorenz Lehmann. "Abatacept/ruxolitinib and Screening for Concomitant Respiratory Muscle Failure to Mitigate Fatality of Immune-checkpoint Inhibitor Myocarditis." Cancer Discovery 13, no. 5 (2023). https://doi.org/10.1158/2159-8290.CD-22-1180.

MLA (9th ed.) Citation

Salem, Joe-Elie, et al. "Abatacept/ruxolitinib and Screening for Concomitant Respiratory Muscle Failure to Mitigate Fatality of Immune-checkpoint Inhibitor Myocarditis." Cancer Discovery, vol. 13, no. 5, 2023, https://doi.org/10.1158/2159-8290.CD-22-1180.